-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AMCu5reFs48ztpsYY9MJVOagVyYMARdP40N7qcV0WQ4DmBZI/oBcbC8VxVaWt9WM Q57hheFVhPatKluMbyLm5g== 0000914260-03-000027.txt : 20030214 0000914260-03-000027.hdr.sgml : 20030214 20030214105318 ACCESSION NUMBER: 0000914260-03-000027 CONFORMED SUBMISSION TYPE: 15-15D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20030214 EFFECTIVENESS DATE: 20030214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATIVE CLINICAL SOLUTIONS LTD CENTRAL INDEX KEY: 0001002022 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 650617076 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 FILING VALUES: FORM TYPE: 15-15D SEC ACT: 1934 Act SEC FILE NUMBER: 033-97854 FILM NUMBER: 03563569 BUSINESS ADDRESS: STREET 1: 10 DORRANCE ST STREET 2: STE 400 CITY: PROVIDENCE STATE: RI ZIP: 02903 BUSINESS PHONE: 4018316755 MAIL ADDRESS: STREET 1: 10 DORRANCE STREET STREET 2: SUITE 400 CITY: PROVIDENCE STATE: RI ZIP: 02903 FORMER COMPANY: FORMER CONFORMED NAME: CONTINUUM CARE CORP DATE OF NAME CHANGE: 19951010 FORMER COMPANY: FORMER CONFORMED NAME: PHYMATRIX CORP DATE OF NAME CHANGE: 19951229 15-15D 1 form15.htm FORM 15D Form 15 ICSL 
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 15

 Certification and Notice of Termination of Registration under Section 12(g) of
    the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
       Under Sections 13 and 15(d) of the Securities Exchange Act of 1934.

                        Commission File Number : 0-27568
                                                 --------

                       INNOVATIVE CLINICAL SOLUTIONS, LTD.
   ------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

                          10 Dorrance Street, Suite 400
                         Providence, Rhode Island 02903
                                 (401) 831-6755
      -------------------------------------------------------------------
   (Address, including zip code, and telephone number, including area code, of
                    registrant's principal executive offices)

                     Common Stock, Par Value $0.01 per share
      -------------------------------------------------------------------
            (Title of each class of securities covered by this Form)

                                      None
         -------------------------------------------------------------
   (Title of all other classes of securities for which a duty to file reports
                      under Section 13(a) or 15(d) remains)

     Please  place  an X in  the  box(es)  to  designate  the  appropriate  rule
provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)(i)             [ X ]     Rule 12h-3(b)(1)(i)         [ X ]
Rule 12g-4(a)(1)(ii)            [   ]     Rule 12h-3(b)(2)(i)         [   ]
Rule 12g-4(a)(2)(i)             [   ]     Rule 12h-3(b)(2)(ii)        [   ]
Rule 12g-4(a)(2)(ii)            [   ]     Rule 12h-3(b)(2)(ii)        [   ]
                                          Rule 15d-6                  [ X ]

     Approximate number of holders of record as of the certification or notice date:  278
                                                                                      ---

     Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,
Innovative Clinical Solutions,  Ltd. has caused this  certification/notice to be
signed on its behalf by the undersigned duly authorized person.


Date:  February 14, 2003             By: /s/ Gerald Hellerman
       -----------------                ---------------------------------------
                                     Name:   Gerald Hellerman
                                     Title:  Director
-----END PRIVACY-ENHANCED MESSAGE-----